EP 0984692 A1 20000315 - NOVEL ANGIOGENESIS INHIBITORS
Title (en)
NOVEL ANGIOGENESIS INHIBITORS
Title (de)
ANGIOGENESE-INHIBITOREN
Title (fr)
NOUVEAUX INHIBITEURS D'ANGIOGENESE
Publication
Application
Priority
- GB 9800681 A 19980114
- US 9810590 W 19980526
- US 4807697 P 19970530
Abstract (en)
[origin: WO9854093A1] The present invention relates to compounds which inhibit tyrosine kinase enzymes, compositions which contain tyrosine kinase inhibiting compounds and methods of using tyrosine kinase inhibitors to treat tyrosine kinase-dependent diseases/conditions such as angiogenesis, cancer, atherosclerosis, diabetic retinopathy or autoimmune diseases, in mammals.
IPC 1-7
IPC 8 full level
A61K 31/519 (2006.01); A61P 9/14 (2006.01); A61P 17/06 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 487/04 (2006.01)
CPC (source: EP)
A61P 9/14 (2017.12); A61P 17/06 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 487/04 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9854093 A1 19981203; AU 734009 B2 20010531; AU 7594498 A 19981230; CA 2291709 A1 19981203; EP 0984692 A1 20000315; EP 0984692 A4 20010221; JP 2002501532 A 20020115
DOCDB simple family (application)
US 9810590 W 19980526; AU 7594498 A 19980526; CA 2291709 A 19980526; EP 98923719 A 19980526; JP 50079099 A 19980526